title: [Alginates in the treatment of postgastroresection reflux esophagitis].
abstract: OBJECTIVE
  To evaluate the efficacy of alginates in the treatment of postgastroresection reflux esophagitis.
  
  
  METHODS
  Thirty-four post-Billroth II distal gastrectomy patients with reflux esophagitis and without erosive and ulcerative lesions of the gastric stump and anastomosis, who had received geviscon monotherapy for 6 weeks, were examined. Their symptoms and the data of esophagogastroduodenoscopy and impedance pH monitoring were assessed to control treatment results.
  
  
  RESULTS
  There was statistically significant relief of the subjective (heartburn and bitter taste in the mouth) and objective symptoms of the disease and the reflux esophagitis in geviscon-treated patients.
  
  
  CONCLUSIONS
  Geviscon is the drug of choice for treating reflux esophagitis in patients after partial distal gastrectomy provided that the acid-forming function of the gastric mucosa is minimally preserved.
authors.forename: O B
authors.initials: OB
authors.lastname: Ianova
authors.forename: V A
authors.initials: VA
authors.lastname: Kim
authors.forename: E V
authors.initials: EV
authors.lastname: Treĭman
mesh_terms: D000464:Alginates / Q000008:administration & dosage*; D000536:Aluminum Hydroxide / Q000008:administration & dosage*; D004338:Drug Combinations; D016145:Endoscopy, Digestive System; D004942:Esophagitis, Peptic / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005743:Gastrectomy / Q000009:adverse effects*; D005763:Gastroenterostomy / Q000009:adverse effects*; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008875:Middle Aged; D012824:Silicic Acid / Q000008:administration & dosage*; D017693:Sodium Bicarbonate / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D000464:Alginates; D004338:Drug Combinations; D012824:Silicic Acid; D000536:Aluminum Hydroxide; C007829:alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination; D017693:Sodium Bicarbonate